Citigroup’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-68
| Closed | -$136 | – | 5900 |
|
|
2023
Q1 | $136 | Hold |
68
| – | – | ﹤0.01% | 5272 |
|
|
2022
Q4 | $248 | Hold |
68
| – | – | ﹤0.01% | 5576 |
|
|
2022
Q3 | $0 | Sell |
68
-131
| -66% | -$931 | ﹤0.01% | 6599 |
|
|
2022
Q2 | $1K | Buy |
199
+55
| +38% | +$513 | ﹤0.01% | 6164 |
|
|
2022
Q1 | $2K | Sell |
144
-378
| -72% | -$4.82K | ﹤0.01% | 6125 |
|
|
2021
Q4 | $8K | Buy |
522
+242
| +86% | +$5.12K | ﹤0.01% | 5614 |
|
|
2021
Q3 | $7K | Buy |
280
+196
| +233% | +$5.89K | ﹤0.01% | 5562 |
|
|
2021
Q2 | $3K | Sell |
84
-35
| -29% | -$1.39K | ﹤0.01% | 5951 |
|
|
2021
Q1 | $6K | Sell |
119
-244
| -67% | -$14.1K | ﹤0.01% | 5868 |
|
|
2020
Q4 | $18K | Buy |
363
+277
| +322% | +$10.4K | ﹤0.01% | 6729 |
|
|
2020
Q3 | $3K | Sell |
86
-156
| -64% | -$8.79K | ﹤0.01% | 7257 |
|
|
2020
Q2 | $17K | Buy |
+242
| New | +$9.65K | ﹤0.01% | 6754 |
|
|
2019
Q4 | – | Sell |
-154
| Closed | -$2K | – | 7867 |
|
|
2019
Q3 | $2K | Sell |
154
-157
| -50% | -$1.4K | ﹤0.01% | 7571 |
|
|
2019
Q2 | $3K | Sell |
311
-36
| -10% | -$366 | ﹤0.01% | 7587 |
|
|
2019
Q1 | $5K | Sell |
347
-30
| -8% | -$348 | ﹤0.01% | 7434 |
|
|
2018
Q4 | $3K | Buy |
377
+199
| +112% | +$3.49K | ﹤0.01% | 7478 |
|
|
2018
Q3 | $4K | Buy |
178
+141
| +381% | +$5.36K | ﹤0.01% | 7539 |
|
|
2018
Q2 | $2K | Buy |
37
+28
| +311% | +$1.39K | ﹤0.01% | 7490 |
|
|
2018
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 7728 |
|
|
2017
Q4 | $0 | Buy |
9
+5
| +125% | +$265 | ﹤0.01% | 7694 |
|
|
2017
Q3 | $0 | Sell |
4
-33
| -89% | -$1.93K | ﹤0.01% | 7517 |
|
|
2017
Q2 | $2K | Sell |
37
-477
| -93% | -$26.4K | ﹤0.01% | 7052 |
|
|
2017
Q1 | $38K | Sell |
514
-444
| -46% | -$49.4K | ﹤0.01% | 5891 |
|
|
2016
Q4 | $143K | Buy |
958
+922
| +2,561% | +$163K | ﹤0.01% | 5553 |
|
|
2016
Q3 | $7K | Buy |
+36
| New | +$6.62K | ﹤0.01% | 6688 |
|
Citigroup's NH Position: Q2 2023 in Review
Citigroup sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 68 shares — an estimated $136 sold.
Citigroup first reported a position in NH in Q3 2016 and held it in 25 quarters. The position peaked at $143K in Q4 2016. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Citigroup reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Citigroup sold 68 NantHealth, Inc shares in Q2 2023, an estimated $136.
- Citigroup first reported a position in NantHealth, Inc in Q3 2016 and held it in 25 quarters.
- Citigroup's NantHealth, Inc position peaked at $143K in Q4 2016.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.